Oncolytic viral therapy for pancreatic cancer: current research and future directions

被引：16

作者：

Ady, Justin W. ^{[1
]}

Heffner, Jacqueline ^{[1
]}

Klein, Elizabeth ^{[1
]}

Fong, Yuman ^{[1
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA

来源：

ONCOLYTIC VIROTHERAPY | 2014年 / 3卷

关键词：

pancreatic cancer; oncolytic virus; review;

D O I：

10.2147/OV.S53858

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The development of targeted agents and chemotherapies for pancreatic cancer has only modestly affected clinical outcome and not changed 5-year survival. Fortunately the genetic and molecular mechanisms underlying pancreatic cancer are being rapidly uncovered and are providing opportunities for novel targeted therapies. Oncolytic viral therapy is one of the most promising targeted agents for pancreatic cancer. This review will look at the current state of the development of these self-replicating nanoparticles in the treatment of pancreatic cancer.

引用

页码：35 / 46

页数：12

共 120 条

[51] Modified vaccinia Ankara expressing survivin combined with gemcitabine generates specific antitumor effects in a murine pancreatic carcinoma model [J].

Ishizaki, Hidenobu ;

Manuel, Edwin R. ;

Song, Guang-Yun ;

Srivastava, Tumul ;

Sun, Sabrina ;

Diamond, Don J. ;

Ellenhorn, Joshua D. I. .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2011, 60 (01) :99-109

[52] Core signaling pathways in human pancreatic cancers revealed by global genomic analyses [J].

Jones, Sian ;

Zhang, Xiaosong ;

Parsons, D. Williams ;

Lin, Jimmy Cheng-Ho ;

Leary, Rebecca J. ;

Angenendt, Philipp ;

Mankoo, Parminder ;

Carter, Hannah ;

Kamiyama, Hirohiko ;

Jimeno, Antonio ;

Hong, Seung-Mo ;

Fu, Baojin ;

Lin, Ming-Tseh ;

Calhoun, Eric S. ;

Kamiyama, Mihoko ;

Walter, Kimberly ;

Nikolskaya, Tatiana ;

Nikolsky, Yuri ;

Hartigan, James ;

Smith, Douglas R. ;

Hidalgo, Manuel ;

Leach, Steven D. ;

Klein, Alison P. ;

Jaffee, Elizabeth M. ;

Goggins, Michael ;

Maitra, Anirban ;

Iacobuzio-Donahue, Christine ;

Eshleman, James R. ;

Kern, Scott E. ;

Hruban, Ralph H. ;

Karchin, Rachel ;

Papadopoulos, Nickolas ;

Parmigiani, Giovanni ;

Vogelstein, Bert ;

Velculescu, Victor E. ;

Kinzler, Kenneth W. .

SCIENCE, 2008, 321 (5897) :1801-1806

[53] Enhanced therapeutic efficacy of G207 for the treatment of glioma through Musashi1 promoter retargeting of γ34.5-mediated virulence [J].

Kanai, R ;

Tomita, H ;

Shinoda, A ;

Takahashi, M ;

Goldman, S ;

Okano, H ;

Kawase, T ;

Yazaki, T .

GENE THERAPY, 2006, 13 (02) :106-116

[54] Suitability of a US3-inactivated HSV mutant (L1BR1) as an oncolytic virus for pancreatic cancer therapy [J].

Kasuya, H. ;

Nishiyama, Y. ;

Nomoto, S. ;

Goshima, F. ;

Takeda, S. ;

Watanabe, I. ;

Nomura, N. ;

Shikano, T. ;

Fujii, T. ;

Kanazumi, N. ;

Nakao, A. .

CANCER GENE THERAPY, 2007, 14 (06) :533-542

[55]

Kasuya H, 1999, J SURG ONCOL, V72, P136, DOI 10.1002/(SICI)1096-9098(199911)72:3<136::AID-JSO5>3.0.CO

[56]

2-3

[57] Poxvirus-based vaccine therapy for patients with advanced pancreatic cancer [J].

Kaufman, Howard L. ;

Kim-Schulze, Seunghee ;

Manson, Kelledy ;

DeRaffele, Gail ;

Mitcham, Josephine ;

Seo, Kang Seok ;

Kim, Dae Won ;

Marshall, John .

JOURNAL OF TRANSLATIONAL MEDICINE, 2007, 5 (1)

[58]

Kimata H, 2003, HEPATO-GASTROENTEROL, V50, P961

[59] Targeted and armed oncolytic poxviruses: a novel multi-mechanistic therapeutic class for cancer [J].

Kirn, David H. ;

Thorne, Steve H. .

NATURE REVIEWS CANCER, 2009, 9 (01) :64-71

[60] Pancreatic carcinogenesis [J].

Koorstra, Jan-Bart M. ;

Hustinx, Steven R. ;

Offerhaus, G. Johan A. ;

Maitra, Anirban .

PANCREATOLOGY, 2008, 8 (02) :110-125

← 1 2 3 4 5 6 7 8 9 10 →